Oppilotech Ltd

I have a PhD studentship available exploring new ways to 'drug' the RAS-RAF-MEK-ERK1/2 pathway. A collaboration with the good people of @PhoreMostLtd so you will benefit from both an academic and commercial perspective. And we are a friendly bunch! babraham.ac.uk/work-and-study…

⚠️⚠️ ANNOUNCEMENT ⚠️⚠️ A special project we’ve been working on will air tomorrow Monday 26th September at 7pm across all my socials. All the support and encouragement this far is greatly appreciated & I can’t wait to share this video with you all as we edge closer to Day 365

Today we announce our co-development drug discovery partnership with @EvaristeTechno1, using machine learning and artificial intelligence to establish a first-in-class antibacterial programme. #biotech oppilotech.com/1934-2/

Finland detects UK & SA variants. As immune pressure on virus grows, evolution will speed up & any variants that escape that immunity will have selective advantage. Both variants huge worry, variant described SA, may already evade mAbs, variant UK more transmissible

Great PhD opportunity with @FrancesPearl2 @SussexLifeSci and @Oppilotech using AI to model DDR pathways in cancer @ukgsn @GDSC_Sussex

Exciting PhD studentship working with @Oppilotech & @SussexUni on DNA Damage Response Pathways southcoastbiosciencesdtp.ac.uk/project/dynami…

First residents announced - @Oppilotech ,#Exogene & @ImmtuneT as @SteBioCat announces the opening of the lab hotel. Read more - ukspa.org.uk #ukspa #science #innovation #incubation #startups #research #scienceparks #laboratory #labspace

What a great film!! Lovely to see you in the movies @Stephen_Curry and also some other people I've met! (@JennyRohn & Bernadette Byrne) 👏🏻👏🏻👏🏻 @Dr_RKarda @DrJo_Ng @jowinx @Ajmistry1 @_BSGCT @ESGCT @reneewatson77 @alanlparker @DrNLK0

@SimonWad @Stephen_Curry @JennyRohn @Dr_RKarda @DrJo_Ng @jowinx @Ajmistry1 @_BSGCT @ESGCT @reneewatson77 @alanlparker @DrNLK0 Totally agree!! Great to see @laurencepearl “we’re just scratching not even the surface..the dust on the surface” A lot of research to do!

BBC News - CEO Secrets: ‘What I learned from leaders’ behaviour off-camera’ bbc.co.uk/news/business-…

Scoop: Several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products. buff.ly/2CLrTZD

.@Oppilotech - one of the 2018 Accelerate@Babraham cohort - is raising capital to expand the team and progress its work on cancer pathways. Founder and CEO @Ajmistry1 sets out his strategy to @businessweekly here: businessweekly.co.uk/trade-floor/in…

Cambridge startup raising capital to transform drug target selection bit.ly/344X0Jt @Oppilotech @Ajmistry1 #biology #drugdiscovery #Ecoli #MachineLearning

This is GAME CHANGER. Abbott to market, starting next week, a fast point-of-care #coronavirus test, delivering positive results in 5min and negative results in 13min. Will deliver 50K tests/day to start. Kudos to Abbott and FDA’s Jeff Shuren and team at CDRH who are in the fight.

Our Charity Committee has chosen Maggie’s cancer support centres as our next good cause to support: maggiescentres.org And YOU can help them! RxCelerate will donate £5 to Maggie’s for every @Twitter follower we gain between now and Christmas Eve. Please RT!

Serial Atlas entrepreneur/exec Nessan Bermingham unveils the Triplet Therapeutics story: new startup targeting novel biology to address triplet repeat expansion disorders such as Huntington’s and Myotonic Dystrophy. triplettx.com #AtlasRetreat2019

#BioCap19 Discover the technologies revolutionising the Health Tech and Digital sector! Hear from Natalio Krasnogor @portabolomics Stuart Hendry @rinicare Jane Theaker at Kinomica Ajay Mistry @Oppilotech Book Now! @Bionow ow.ly/Z6Bh50wojDZ